Pfizer CEO Albert Bourla was diagnosed positive for the coronavirus. The head of the pharmaceutical giant announced that he has received four doses of the vaccine and is being treated with the antiviral pill Paxlovid. His post:

I would like to let you know that I have tested positive for #COVID19. I am thankful to have received four doses of the Pfizer-BioNTech vaccine, and I am feeling well while experiencing very mild symptoms. I am isolating and have started a course of Paxlovid.

— Albert Bourla (@AlbertBourla) August 15, 2022

>Related articles

Two deaths from influenza and one from COVID-19 in the past week – What the HCDCP report states

Scientists’ alert on avian flu – Could cause a pandemic worse than COVID-19

Kontoaggelos to Proto Thema: “COVID-19 triggered depression, but not psychiatric drug use” – Supporting cancer patients and answering the hard questions

We have come so far in our efforts to combat this disease that I am confident of a speedy recovery. I am incredibly grateful for the continued efforts of my colleagues at Pfizer who have worked to make vaccines and treatments available to me and to people around the world.

Paxlovid is not approved, but has been approved for emergency use by the FDA for the treatment of mild to moderate COVID-19 in high-risk patients 12+, weighing at least 40 kg, with positive SARS-CoV-2 viral test results ».